By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) 

245 First Street
Suite 1800
Cambridge  Massachusetts  02142  U.S.A.
Phone: 503-227-0554 Fax: 503-227-0751



Company News
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
Sarepta Therapeutics (SRPT) Announces Publication Of Ebola And Marburg Phase 1 Clinical Study Results; Contract With BioDefense Therapeutics 10/17/2014 10:38:54 AM
Sarepta Therapeutics (SRPT) Announces Presentations At The 19th International Congress Of The World Muscle Society 10/8/2014 7:53:13 AM
Sarepta Therapeutics (SRPT) Announces Favorable Safety Results From Phase I Clinical Study Of Influenza Drug Candidate 9/30/2014 10:24:24 AM
Sarepta Therapeutics (SRPT) To Present At Leerink Partners Rare Disease Roundtable 9/25/2014 9:38:02 AM
Sarepta Therapeutics (SRPT) To Present Company Overview At Upcoming Conferences 8/28/2014 10:18:28 AM
Sarepta Therapeutics (SRPT) Enters Into Partnership With Flagship Biosciences LLC To Digitally Automate The Measurement Of Dystrophin, A Key Therapeutic Efficacy Marker For Muscular Dystrophy 8/21/2014 10:44:58 AM
Sarepta Therapeutics (SRPT) Announces Second Quarter 2014 Financial Results And Recent Corporate Developments 8/7/2014 10:57:47 AM
Sarepta Therapeutics (SRPT) Should Shut Up About Ebola And Focus On Job No. 1 8/7/2014 6:48:14 AM
Cambridge's Sarepta Therapeutics (SRPT) Gets A Lift As Shelved Ebola Drug Offers Hope In Crisis 8/7/2014 6:38:45 AM